Yahoo! Finance
06-11-2008, 10:10 AM
<b>Yahoo! Finance: Mutual Fund News</b>
Rosetta Genomics Ltd. , a leader in the development of microRNA-based diagnostics and therapeutics, announced today that it has signed a binding term sheet to acquire Parkway Clinical Laboratories Inc. , a privately-held CLIA-certified lab located in Bensalem, Pennsylvania, for an aggregate purchase price of $2,900,000, consisting of $1,900,000 in cash and $1,000,000 of Rosetta's ordinary shares.
complete story here... (http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080611/ukw009.html?.v=101)
Rosetta Genomics Ltd. , a leader in the development of microRNA-based diagnostics and therapeutics, announced today that it has signed a binding term sheet to acquire Parkway Clinical Laboratories Inc. , a privately-held CLIA-certified lab located in Bensalem, Pennsylvania, for an aggregate purchase price of $2,900,000, consisting of $1,900,000 in cash and $1,000,000 of Rosetta's ordinary shares.
complete story here... (http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080611/ukw009.html?.v=101)